Is CORD up or down today?
CORD is up 0.69% today, last at 2.93. This stock moved +0.69% versus the prior close.
CORD · CORD
CORD (CORD) is trading at 2.93, up 0.69% on the session. CORD sits at the 2% mark of its 52-week range, carries a 14-day RSI of 42, and trades below its 50-day average. Over the past month it is up 28.51%.
Leading the coverage: “Spinal Cord Injury Market is Projected to Witness Significant Growth by 2036 Owing to the Expansion of Neuroprotective and Regenerative Therapies | DelveInsight - Barchart.com” (Google News Company, 10d ago). CORD is -15.80% since story.
CORD trades on a trailing P/E of 25.7 and is running 29.57% ahead of the S&P 500 over the same stretch.
Analyst firms are mostly reiterating — no strong directional shift lately.
CORD is up 0.69% today, last at 2.93. This stock moved +0.69% versus the prior close.
Leading the coverage: “Spinal Cord Injury Market is Projected to Witness Significant Growth by 2036 Owing to the Expansion of Neuroprotective and Regenerative Therapies | DelveInsight - Barchart.com” (Google News Company, 10d ago). CORD is -15.80% since story. Dominant story: Spinal Cord Injury Market is Projected to Witness Significant Growth by 2036 Owing to the Expansion of Neuroprotective and Regenerative Therapies | DelveInsight - Barchart.com (1 source, bullish) RSI is 42 — leaning bearish Price below 50-day average — short-term weakness Social sentiment loads separately — see the Social tab.
Analyst firms are mostly reiterating — no strong directional shift lately.
Loaded: Mar 2026 – Sep 2026 (124 days) · Drag or scroll left for earlier dates
Spinal Cord Injury Market is Projected to Witness Significant Growth by 2036 Owing to the Expansion of Neuroprotective and Regenerative Therapies | DelveInsight - Barchart.com
Hurry: Google Pixel 11 Stock Is Running Low, But You Could Pay as Little as $299 While Supplies Last - | Cord Cutters News
Cord-Cutters Flocked to Paramount+, Netflix and Peacock’s Ad-Free Plans in Q1 - TheWrap
Stock Up & Save! Buy $50 of Everyday Needs Like Glad, Kleenex, Tide, Mrs Meyer’s, etc. & Get $15 on Amazon For a Limited Time - | Cord Cutters News
【Kringle Pharma FY2026 Q3 Earnings Call】Phase 3 Additional Trial for Spinal Cord Injury Begins, Basic Agreement with Maruishi Pharmaceutical for Vocal Fold Fibrosis Sales, Full-Year Revenue ¥323 Million - finance.biggo.com